Loading...
XNSE
ERIS
Market cap2.29bUSD
Nov 12, Last price  
1,575.20INR
Name

Eris Lifesciences Ltd

Chart & Performance

D1W1MN
XNSE:ERIS chart
P/E
35.23
P/S
6.97
EPS
44.71
Div Yield, %
—
Shrs. gr., 5y
0.12%
Rev. gr., 5y
21.28%
Revenues
31.29b
+8.69%
2,739,400,0003,930,640,0005,088,220,0005,455,580,0005,970,210,0007,494,960,0008,271,040,0009,672,020,00010,581,830,00011,926,440,00013,261,680,00016,618,160,00019,913,000,00028,792,600,00031,294,200,000
Net income
6.20b
+76.08%
369,430,000581,980,000704,190,000892,340,0001,335,690,0002,467,850,0002,941,050,0002,907,960,0002,964,970,0003,551,350,0004,061,130,0003,821,580,0003,920,500,0003,518,400,0006,195,200,000
CFO
3.47b
-67.42%
302,990,000380,150,000896,240,000900,570,0001,314,790,0001,998,650,0002,346,350,0002,229,960,0002,711,100,0003,753,610,0003,782,640,0002,917,380,0004,860,050,00010,650,100,0003,469,300,000
Dividend
Feb 13, 20257.35 INR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Eris Lifesciences Limited is an Indian pharmaceutical company engaged in the manufacturing, marketing, and distribution of medicinal products throughout the country. The company provides a comprehensive range of branded formulations, catering to a wide spectrum of therapeutic areas. These encompass cardiovascular health, anti-diabetic treatments, anti-infectives, antipyretics, vitamin/nutrient supplements, gastroenterology, respiratory care, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, alongside services in in-vitro fertilization, cosmetology, and dermatology. Founded in 2007, Eris Lifesciences Limited is headquartered in Ahmedabad, India.
URL
https://eris.co.in/
IPO date
Jun 29, 2017
Employees
Domiciled in
IN
Incorporated in
IN

Valuation

Title
INR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT